Consequently, GABA uptake inhibitors have emerged as potential therapeutic agents for these conditions, leading to increased interest in the development of new compounds that can effectively ...

Ovid is developing: OV329, a next-generation GABA-aminotransferase inhibitor, as a potential therapy for treatment-resistant ...

"While early, we believe OV329's promise is quite real as a potential best-in-class next-generation GABA-AT inhibitor," the bank said in a note. Oppenheimer said that while it was unsure which ...